Wendy DiCicco
Region: US Northeast
Wendy DiCicco is a highly accomplished life sciences board member and financial/operating executive with over 30 years of demonstrated, strategic experience leading public and private companies through periods of accelerated growth, reorganization, and transformation including through early stages of development, clinical trials, and global commercialization. She also brings proven results in the establishment and expansion of global businesses throughout the EMEA and APAC regions.
Key Positions
- CFO, Renovacor, Inc.
- CFO, FerGene, Inc.
- COO & CFO, Centinel Spine, Inc.
- President and COO, Camber Spine Technologies
- VP, Treasurer, and CFO, Nuron Biotech
- CFO, Quench USA, Inc.
- CFO, Globus Medical
- CFO, Kensey Nash Corporation
Board Positions
- EyePoint Pharmaceuticals
- Imvax Therapeutics
- ExpressCells
- II-VI, Inc.
- SWK Holdings
- Sincerus Pharmaceuticals
- Carmell Therapeutics
- SynCardia Systems
- CannaPharma Rx
Key Industries
- Life Sciences
Core Strengths
- Mergers & Acquisitions
- Global Expansion
- Strategic Growth & Capitalization
- Operations Management
- Capital Raise
- Culture Development
